ofloxacin has been researched along with sulfamethoxazole in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (20.97) | 18.7374 |
| 1990's | 3 (4.84) | 18.2507 |
| 2000's | 16 (25.81) | 29.6817 |
| 2010's | 16 (25.81) | 24.3611 |
| 2020's | 14 (22.58) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Becker, EW; Berg, PA; Hofer, T; Weigand, K | 1 |
| Katoh, O; Kuroki, S; Nagasawa, Z; Nakanishi, Y; Yamada, H; Yamaguchi, M | 1 |
| Birnbaum, D; Krause, B; Lenk, V; Trautmann, M; Wagner, J | 1 |
| Kawaguchi, K; Yamaguchi, K | 1 |
| Brust, P; Hooton, TM; Johnson, CR; Opheim, K; Stamm, WE; Tartaglione, TA | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Cullmann, W; Dechène, M; Stieglitz, M | 1 |
| Akin, A; Aydin, M; Unal, S | 1 |
| Forsgren, A; Ode, B; Walder, M | 1 |
| Carlstedt-Duke, B; Høverstad, T; Lingaas, E; Midtvedt, T; Norin, KE; Saxerholt, H; Steinbakk, M | 1 |
| Battaglia, AM; Battaglia, P; Bernardini, G; Vellucci, A | 1 |
| Bjertnaes, A; Block, JM; Hafstad, PE; Holte, M; Ottemo, I; Peterson, LE; Rolstad, T; Svarva, PL; Walstad, RA | 1 |
| Ludwig, G; Pauthner, H | 1 |
| Wittenberger, R | 1 |
| Callery, SV; Cox, CE; Tack, KJ | 1 |
| Arvieux, C; Avril, JL; Cartier, F; Jacquelinet, C; Michelet, C; Vu, N | 1 |
| Choquet-Kastylevsky, G; Descotes, J; Faure, L; Ravel, G; Ruat, C | 1 |
| Nierkens, S; Nieuwenhuijsen, L; Pieters, R; Thomas, M | 1 |
| Ferrari, B; Fraysse, B; Garric, J; Lo Giudice, R; Mons, R; Paxéus, N; Pollio, A; Vollat, B | 1 |
| Felmingham, D | 1 |
| Brain, RA; Hanson, ML; Johnson, DJ; Lam, MW; Mabury, SA; Richards, SM; Sanderson, H; Sibley, PK; Solomon, KR; Young, C | 1 |
| Drillia, P; Fountoulakis, M; Lyberatos, G; Stamatelatou, K | 1 |
| Dokianakis, SN; Kornaros, ME; Lyberatos, G | 1 |
| Naber, KG; Schinzel, S; Wagenlehner, C; Wagenlehner, FM | 1 |
| Arnold, FW; Wojda, B | 1 |
| Drillia, P; Lyberatos, G; Stamatelatou, K | 1 |
| Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA | 1 |
| Lajiness, MJ | 1 |
| Akiyama, T; Savin, MC | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Herodes, K; Kipper, K; Leito, I; Nei, L | 1 |
| Berthe, T; Budzinski, H; Capdeville, MJ; Oberlé, K; Petit, F | 1 |
| Mossa, HA; Salem, AA | 1 |
| Malato, S; Miralles-Cuevas, S; Oller, I; Pérez, JA | 1 |
| Esfahani, HM; Kargosha, K; Rashvand, M; Salemi, A; Vosough, M | 1 |
| Bouyarmane, H; Coradin, T; El Hanbali, I; El Karbane, M; Laghzizil, A; Masse, S; Rami, A; Saoiabi, A; Saoiabi, S | 1 |
| Feng, G; Gao, X; Guo, JS; Sun, C; Yan, Q; Zhu, Z | 1 |
| Li, H; Liang, N; Pan, B; Wu, M; Zhang, D; Zheng, N | 1 |
| Ghosh, S; Li, H; Pan, B; Wang, P; Zhang, D; Zhang, H | 1 |
| Guo, X; Liu, X; Lu, S; Lv, Y; Xi, B; Xu, J; Xu, K | 1 |
| Li, Y; Liu, X; Lv, Y; Xu, K | 1 |
| Li, L; Li, M; Liu, X; Lu, S; Xu, J; Zhang, G; Zhao, B | 1 |
| Guo, X; Liu, X; Lu, S; Lv, Y; Xu, J | 1 |
| Green, MD; Khanthavong, M; Mayxay, M; Newton, PN; Phonlavong, C; Sengaloundeth, S; Sichanh, C; Swamidoss, I; Tabernero, P; Vilayhong, C | 1 |
| Ormeno-Cano, N; Radjenovic, J | 1 |
| Chiron, S; de Melo Costa Serge, N; Goetz, V; Li, C; Nogueira, RFP | 1 |
| Clark, S; Clees, WI; Elkin, KR; Elliott, HA; Hayden, KR; Jones, M; Mashtare, ML; Preisendanz, HE; Read, AF; Richard, TL; Shreve, MJ; Silverman, J; Veith, TL; Watson, JE | 1 |
| Bai, H; Chen, J; Gao, FZ; He, LX; He, LY; Hu, LX; Liu, YS; Yang, YY; Ying, GG; Zhao, JL | 1 |
| Cao, Z; Li, X; Lu, Y; Mao, R; Song, S; Sun, B; Wang, C; Wang, R; Zhang, M | 1 |
| Chen, Y; Cui, K; Ding, Y; Liu, X; Qin, X | 1 |
| Cruz-Monzon, J; De La Cruz-Noriega, M; Gallozzo Cardenas, M; Gamez-Jara, A; Rodríguez-Serin, H; Rodriguez-Yupanqui, M; Rojas-Flores, S | 1 |
| Fang, Y; Liu, Y; Zhang, J | 1 |
| Abudi, ZN; Cheng, L; Hu, Q; Hu, Z; Li, B; Wang, W; Wei, M | 1 |
2 review(s) available for ofloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Comparative antimicrobial susceptibility of respiratory tract pathogens.
Topics: Asia, Eastern; Bacterial Infections; Drug Resistance, Microbial; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Respiratory Tract Diseases; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim | 2004 |
Literature Review: Evaluation of Drug Removal Techniques in Municipal and Hospital Wastewater.
Topics: Anti-Bacterial Agents; Carbamazepine; Diclofenac; Hospitals; Naproxen; Norfloxacin; Ofloxacin; Ozone; Pharmaceutical Preparations; Sewage; Sulfamethoxazole; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2022 |
8 trial(s) available for ofloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis.
Topics: Administration, Oral; Adult; Body Fluids; Cystitis; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Humans; Ofloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vagina; Vaginal Smears | 1988 |
Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females.
Topics: Anti-Infective Agents, Urinary; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infections; Female; Humans; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Ofloxacin vs. cotrimoxazole in patients with complicated urinary tract infections.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Drug Combinations; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis.
Topics: Acute Disease; Anti-Infective Agents; Cystitis; Drug Combinations; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Pregnancy; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin.
Topics: Anti-Infective Agents; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Oxazines; Respiratory Tract Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
[Ofloxacin versus pipemidic acid and co-trimoxazole].
Topics: Adult; Anti-Infective Agents, Urinary; Bacteria; Bacterial Infections; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Nicotinic Acids; Ofloxacin; Oxazines; Pipemidic Acid; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Clinical experience with ofloxacin in urinary tract infection.
Topics: Anti-Infective Agents; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Ofloxacin; Oxazines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract; Urinary Tract Infections | 1986 |
Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
Topics: Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Drug Therapy, Combination; Humans; Levofloxacin; Male; Ofloxacin; Prospective Studies; Prostatectomy; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2005 |
52 other study(ies) available for ofloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Demonstration of sensitized lymphocytes to trimethoprim/sulfamethoxazole and ofloxacin in a patient with cholestatic hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Hypersensitivity; Female; Humans; Ofloxacin; Sulfamethoxazole; T-Lymphocytes; Trimethoprim | 1992 |
[A case of pulmonary nocardiosis associated with middle lobe atelectasis].
Topics: Aged; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Lung Diseases; Nocardia asteroides; Nocardia Infections; Ofloxacin; Pulmonary Atelectasis; Sulfamethoxazole; Trimethoprim | 1990 |
Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.
Topics: Adult; Amoxicillin; Chloramphenicol; Ciprofloxacin; Drug Combinations; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxazines; Quinolines; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
[Single day treatment in acute cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cystitis; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Humans; Middle Aged; Norfloxacin; Ofloxacin; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Humans; Mutation; Ofloxacin; Serratia marcescens; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
Topics: Anti-Bacterial Agents; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Influence of antibiotics on intestinal mucin in healthy subjects.
Topics: Administration, Oral; Adult; Ampicillin; Anti-Bacterial Agents; Bacitracin; Clindamycin; Doxycycline; Drug Combinations; Electrophoresis, Agar Gel; Erythromycin; Feces; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Metronidazole; Mucins; Nalidixic Acid; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes.
Topics: Amoxicillin; Anti-Infective Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluoroquinolones; HeLa Cells; Humans; Levofloxacin; Listeria monocytogenes; Ofloxacin; Quinolones; Rifampin; Sulfamethoxazole; Trimethoprim | 1997 |
Tritiated thymidine incorporation does not enhance sensitivity of the popliteal lymph node assay.
Topics: Animals; Drug Evaluation, Preclinical; Female; Local Lymph Node Assay; Lymph Nodes; Male; Metformin; Mice; Mice, Inbred BALB C; Ofloxacin; Phenobarbital; Phenytoin; Random Allocation; Streptozocin; Sulfamethoxazole; Thymidine; Tritium | 2003 |
Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs.
Topics: Animals; Antigens; B-Lymphocytes; Drug Evaluation, Preclinical; Ear, External; Female; Ficoll; Immunization; Immunosuppressive Agents; Injections, Intradermal; Injections, Subcutaneous; Interferon Type I; Interferon-gamma; Local Lymph Node Assay; Lymph Nodes; Mice; Mice, Inbred BALB C; Ofloxacin; Ovalbumin; Phenytoin; Sulfamethoxazole; T-Lymphocytes | 2004 |
Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?
Topics: Animals; Carbamazepine; Clofibric Acid; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Environmental Monitoring; France; Germany; Humans; Ofloxacin; Pharmaceutical Preparations; Propranolol; Risk Assessment; Sulfamethoxazole; Toxicity Tests; Water Pollutants, Chemical | 2004 |
Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum.
Topics: Acetaminophen; Analysis of Variance; Atorvastatin; Biological Assay; Biomass; Caffeine; Carbamazepine; Complex Mixtures; Dose-Response Relationship, Drug; Heptanoic Acids; Heterocyclic Compounds; Levofloxacin; Magnoliopsida; Ofloxacin; Pharmaceutical Solutions; Pyrroles; Sertraline; Sulfamethoxazole; Toxicity Tests; Trimethoprim; Water Pollutants, Chemical | 2004 |
Toxic effect of pharmaceuticals on methanogenesis.
Topics: Bacteria, Anaerobic; Biomass; Carbamazepine; Clofibric Acid; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Methane; Methanomicrobiales; Ofloxacin; Pharmaceutical Preparations; Propranolol; Sewage; Sulfamethoxazole; Time Factors; Toxicity Tests; Waste Disposal, Fluid | 2004 |
On the effect of pharmaceuticals on bacterial nitrite oxidation.
Topics: Bacteria, Anaerobic; Biodegradation, Environmental; Bioreactors; Carbamazepine; Cities; Clofibrate; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Kinetics; Nitrites; Nitrogen; Ofloxacin; Oxidation-Reduction; Pharmaceutical Preparations; Propranolol; Sewage; Sulfamethoxazole; Triclosan; Waste Disposal, Fluid; Water Purification | 2004 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Fate and mobility of pharmaceuticals in solid matrices.
Topics: Adsorption; Aluminum Silicates; Bacteria, Aerobic; Bacteria, Anaerobic; Carbamazepine; Carbon; Clay; Clofibric Acid; Diclofenac; Models, Theoretical; Ofloxacin; Pharmaceutical Preparations; Propranolol; Sewage; Soil; Sulfamethoxazole; Water Movements; Water Pollutants, Chemical | 2005 |
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical | 2007 |
Common antibiotics for the treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Humans; Nitrofurantoin; Nurse's Role; Ofloxacin; Patient Education as Topic; Patient Selection; Sulfamethoxazole; Urinary Tract Infections | 2008 |
Populations of antibiotic-resistant coliform bacteria change rapidly in a wastewater effluent dominated stream.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Environmental Monitoring; Escherichia coli; Ofloxacin; Rivers; Sulfamethoxazole; Tetracycline; Trimethoprim; Waste Disposal, Fluid; Water Microbiology; Water Pollutants, Chemical | 2010 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Two fluoroalcohols as components of basic buffers for liquid chromatography electrospray ionization mass spectrometric determination of antibiotic residues.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Lactuca; Mass Spectrometry; Norfloxacin; Ofloxacin; Propanols; Spectrometry, Mass, Electrospray Ionization; Sulfadimethoxine; Sulfamethoxazole | 2011 |
Evidence for a complex relationship between antibiotics and antibiotic-resistant Escherichia coli: from medical center patients to a receiving environment.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Drug Resistance, Bacterial; Escherichia coli; France; Genes, MDR; Hospitals; Ofloxacin; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Water Pollutants, Chemical | 2012 |
Method validation and determinations of levofloxacin, metronidazole and sulfamethoxazole in an aqueous pharmaceutical, urine and blood plasma samples using quantitative nuclear magnetic resonance spectrometry.
Topics: Humans; Levofloxacin; Magnetic Resonance Spectroscopy; Maleates; Metronidazole; Ofloxacin; Sensitivity and Specificity; Sulfamethoxazole; Temperature | 2012 |
Application of solar photo-Fenton at circumneutral pH to nanofiltration concentrates for removal of pharmaceuticals in MWTP effluents.
Topics: Biological Oxygen Demand Analysis; Hydrogen Peroxide; Hydrogen-Ion Concentration; Iron; Light; Ofloxacin; Oxidation-Reduction; Pharmaceutical Preparations; Photolysis; Sulfamethoxazole; Sunlight; Ultrafiltration; Water Pollutants, Chemical; Water Purification | 2015 |
Direct analysis of six antibiotics in wastewater samples using rapid high-performance liquid chromatography coupled with diode array detector: a chemometric study towards green analytical chemistry.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Green Chemistry Technology; Metronidazole; Ofloxacin; Sulfadiazine; Sulfamerazine; Sulfamethoxazole; Wastewater; Water Pollutants, Chemical | 2015 |
Parameters influencing ciprofloxacin, ofloxacin, amoxicillin and sulfamethoxazole retention by natural and converted calcium phosphates.
Topics: Adsorption; Amoxicillin; Anti-Bacterial Agents; Calcium Phosphates; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Durapatite; Hydrogen-Ion Concentration; Kinetics; Ofloxacin; Powders; Sulfamethoxazole | 2015 |
Removal of pharmaceutically active compounds (PhACs) and toxicological response of Cyperus alternifolius exposed to PhACs in microcosm constructed wetlands.
Topics: Biodegradation, Environmental; Carbamazepine; Carotenoids; Catalase; Chlorophyll; Chlorophyll A; Cyperus; Ofloxacin; Peroxidase; Roxithromycin; Sulfamethoxazole; Superoxide Dismutase; Waste Disposal, Fluid; Water Pollutants, Chemical; Wetlands | 2016 |
Adsorption mechanism of different organic chemicals on fluorinated carbon nanotubes.
Topics: Adsorption; Benzhydryl Compounds; Halogenation; Nanotubes, Carbon; Norfloxacin; Ofloxacin; Phenanthrenes; Phenols; Polytetrafluoroethylene; Sulfamethoxazole; Thermodynamics | 2016 |
Impact of concentration and species of sulfamethoxazole and ofloxacin on their adsorption kinetics on sediments.
Topics: Adsorption; Anti-Bacterial Agents; Geologic Sediments; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Ofloxacin; Sulfamethoxazole | 2017 |
Accumulation characteristics and biological response of ginger to sulfamethoxazole and ofloxacin.
Topics: Anti-Bacterial Agents; Hydrogen Peroxide; Ofloxacin; Sulfamethoxazole; Zingiber officinale | 2020 |
The tolerance mechanism and accumulation characteristics of Phragmites australis to sulfamethoxazole and ofloxacin.
Topics: Anti-Bacterial Agents; Biomass; Drug Tolerance; Hydrogen Peroxide; Ofloxacin; Photosynthesis; Plant Leaves; Poaceae; Soil; Sulfamethoxazole; Wetlands | 2020 |
Occurrence of antibiotics and antibiotic resistance genes in the Fuxian Lake and antibiotic source analysis based on principal component analysis-multiple linear regression model.
Topics: Anti-Bacterial Agents; China; Drug Resistance, Microbial; Lakes; Linear Models; Ofloxacin; Principal Component Analysis; Rivers; Sulfamethoxazole; Water Microbiology; Water Pollutants, Chemical | 2021 |
Response of Cyperus involucratus to sulfamethoxazole and ofloxacin-contaminated environments: Growth physiology, transportation, and microbial community.
Topics: Anti-Bacterial Agents; Bacteria; Cyperus; Environmental Pollutants; Genes, Bacterial; Microbiota; Ofloxacin; Rhizosphere; Sulfamethoxazole; Wetlands | 2020 |
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Laos; Ofloxacin; Prevalence; Sulfamethoxazole; Trimethoprim | 2022 |
Electrochemical degradation of antibiotics using flow-through graphene sponge electrodes.
Topics: Anti-Bacterial Agents; Electrodes; Erythromycin; Graphite; Ofloxacin; Oxidation-Reduction; Sulfamethoxazole; Trimethoprim; Water; Water Pollutants, Chemical | 2022 |
Peroxydisulfate activation by CuO pellets in a fixed-bed column, operating mode and assessments for antibiotics degradation and urban wastewater disinfection.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalexin; Clarithromycin; Copper; Disinfection; Escherichia coli; Ofloxacin; Oxidants; Oxides; Phenol; Sulfamethoxazole; Wastewater | 2022 |
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.
Topics: Acetaminophen; Ampicillin; Animals; Anti-Bacterial Agents; COVID-19; Dexamethasone; Doxycycline; Environmental Monitoring; Humans; Hydroxychloroquine; Naproxen; Ofloxacin; Pandemics; Pennsylvania; Pharmaceutical Preparations; Soil; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
The variations of antibiotics and antibiotic resistance genes in two subtropical large river basins of south China: Anthropogenic impacts and environmental risks.
Topics: Anthropogenic Effects; Anti-Bacterial Agents; China; Chlortetracycline; Drug Resistance, Microbial; Ecosystem; Enrofloxacin; Genes, Bacterial; Norfloxacin; Ofloxacin; Oxytetracycline; Rivers; RNA, Ribosomal, 16S; Sulfamethoxazole; Sulfonamides; Water | 2022 |
Contamination, transport, and ecological risks of pharmaceuticals and personal care products in a large irrigation region.
Topics: Caffeine; China; Cosmetics; Ecosystem; Environmental Monitoring; Erythromycin; Humans; Norfloxacin; Ofloxacin; Pharmaceutical Preparations; Risk Assessment; Sulfamethoxazole; Water Pollutants, Chemical | 2022 |
A high-precision prediction for spatiotemporal distribution and risk assessment of antibiotics in an urban watershed using a hydrodynamic model.
Topics: Anti-Bacterial Agents; China; Enrofloxacin; Environmental Monitoring; Erythromycin; Humans; Hydrodynamics; Manure; Norfloxacin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sewage; Sulfamethoxazole; Water Pollutants, Chemical | 2022 |
Mechanisms for the increase in lipid production in cyanobacteria during the degradation of antibiotics.
Topics: Anti-Bacterial Agents; Lipids; Ofloxacin; Photosynthesis; Sulfamethoxazole; Synechococcus | 2023 |
Aerobic granular sludge formation and stability in enhanced biological phosphorus removal system under antibiotics pressure: Performance, granulation mechanism, and microbial successions.
Topics: Aerobiosis; Anti-Bacterial Agents; Bioreactors; Microbiota; Nitrogen; Ofloxacin; Phosphates; Phosphorus; Roxithromycin; Sewage; Sulfamethoxazole; Tetracycline; Waste Disposal, Fluid; Wastewater | 2023 |